CredoScientia - Bibliothèque

Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report.

Intrahepatic cholangiocarcinoma (iCCA) is a highly malignant tumor of the liver and gallbladder, which is usually diagnosed at an advanced stage and the opportunity for surgery is lost. Therefore, con…

Thérapies de Conversion

Zhao, S., Zhang, X., Luo, J., Yan, H., Zhang, J., Lin, R., & Zhu, K. (2024). Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report.. Front Oncol, 14, 1476593. https://doi.org/10.3389/fonc.2024.1476593

01/01/2024 Lire →

Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.

Hepatocellular carcinoma (HCC) represents a significant global health burden, particularly in the Asia-Pacific region, where it is a leading cause of cancer-related mortality. In China alone, HCC acco…

Thérapies de Conversion

Song, P., Tang, W., & Kokudo, N. (2024). Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.. Biosci Trends, 18(6), 495-496. https://doi.org/10.5582/bst.2024.01423

01/01/2024 Lire →

A case report of a patient with stage IIIa hepatocellular carcinoma complicated by early gastric cancer.

We report a case of patient with Stage IIIa Hepatocellular Carcinoma Complicated by Early Gastric Cancer. Although Stage IIIa liver cancer can be treated with surgery, the overall prognosis of surgery…

Thérapies de Conversion

Song, X., Cai, R., Wang, L., Ding, F., & Ni, H. (2024). A case report of a patient with stage IIIa hepatocellular carcinoma complicated by early gastric cancer.. Front Oncol, 14, 1440171. https://doi.org/10.3389/fonc.2024.1440171

01/01/2024 Lire →

Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics Model.

PURPOSE: Predicting the pathological response after neoadjuvant conversion therapy for initially unresectable hepatocellular carcinoma (HCC) is essential for surgical decision-making and survival outc…

Thérapies de Conversion

Wen, H., Liang, R., Liu, X., Yu, Y., Lin, S., Song, Z., Huang, Y., Yu, X., Chen, S., Chen, L., Qian, B., Shen, J., Xiao, H., & Shen, S. (2024). Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics Model.. J Hepatocell Carcinoma, 11, 2145-2157. https://doi.org/10.2147/JHC.S487370

01/01/2024 Lire →

A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection.

PURPOSE: The purpose of This study is exploring the intraoperative and perioperative differences between patients undergoing conversion surgery and those undergoing direct surgery, so as to improve pr…

Thérapies de Conversion

Li, X., Chen, K., Feng, X., Wu, X., Qi, S., Wang, Q., & Shi, Z. (2024). A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection.. J Hepatocell Carcinoma, 11, 2101-2113. https://doi.org/10.2147/JHC.S483397

01/01/2024 Lire →

Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer.

Some special therapeutic responses may appear during immunotherapy, such as hyperprogression, pseudoprogression and so on. Dissociated response of immunotherapy has been clinically reported in recent …

Thérapies de Conversion

Jiang, S., Li, X., & Li, J. (2024). Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer.. Front Immunol, 15, 1460480. https://doi.org/10.3389/fimmu.2024.1460480

01/01/2024 Lire →

Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.

PURPOSE: This study aimed to investigate the benefit of conversion therapy for patients with unresectable hepatocellular carcinoma (HCC).PATIENTS AND METHODS: A retrospective cohort study was conducte…

Thérapies de Conversion

Han, R., Gan, L., Sun, L., Lang, M., Tian, X., Zhu, K., Chen, L., Li, G., & Song, T. (2024). Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.. J Hepatocell Carcinoma, 11, 1835-1844. https://doi.org/10.2147/JHC.S482803

01/01/2024 Lire →

Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.

With the development of comprehensive treatment, locoregional transarterial chemotherapy has become an alternative conversion therapy, palliative therapy, and neoadjuvant therapy for many solid malign…

Thérapies de Conversion

Meng, W., Pan, L., Huang, L., Li, Q., & Sun, Y. (2024). Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.. Front Oncol, 14, 1464242. https://doi.org/10.3389/fonc.2024.1464242

01/01/2024 Lire →

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.

PURPOSE: The aim of this study was to investigate the efficacy and safety of conversion surgery for advanced hepatocellular carcinoma (HCC) after hepatic arterial infusion chemotherapy (HAIC).PATIENTS…

Thérapies de Conversion

Li, W., Zheng, Z., Wang, J., Wu, T., Wang, J., Pan, Y., Chen, J., Hu, D., Xu, L., Zhang, Y., Chen, M., & Zhou, Z. (2024). Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.. J Hepatocell Carcinoma, 11, 463-475. https://doi.org/10.2147/JHC.S447387

01/01/2024 Lire →

Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.

Immunotherapy has demonstrated a role in the therapeutic landscape of a small subset of patients with colorectal carcinoma (CRC) that harbor a microsatellite instability (MSI-H) status due to a defici…

Thérapies de Conversion

San-Román-Gil, M., Martínez-Delfrade, I., Albarrán-Fernández, V., Guerrero-Serrano, P., Pozas-Pérez, J., Chamorro-Pérez, J., Rosero-Rodríguez, D., Sotoca-Rubio, P., Barrill-Corpa, A. M., Alia-Navarro, V., González-Merino, C., García-de-Quevedo-Suero, C., López, V., Ruz-Caracuel, I., Perna-Monroy, C., & Ferreiro-Monteagudo, R. (2024). Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.. Front Immunol, 15, 1352262. https://doi.org/10.3389/fimmu.2024.1352262

01/01/2024 Lire →

Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.

BACKGROUND: The synergistic effect of locoregional therapy in combination with systemic therapy as a conversion therapy for unresectable hepatocellular carcinoma (uHCC) is unclear. The purpose of this…

Thérapies de Conversion

Wu, X. K., Yang, L. F., Chen, Y. F., Chen, Z. W., Lu, H., Shen, X. Y., Chi, M. H., Wang, L., Zhang, H., Chen, J. F., Huang, J. Y., Zeng, Y. Y., Yan, M. L., & Zhang, Z. B. (2024). Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.. EClinicalMedicine, 67, 102367. https://doi.org/10.1016/j.eclinm.2023.102367

01/01/2024 Lire →

Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy.

OBJECTIVE: To explore the prognostic impact of contrast-enhanced ultrasound (CEUS) features for initially unresectable colorectal liver metastases (CLMs) in a clinical setting of conversion therapy.ME…

Thérapies de Conversion

Zhang, X. L., Wang, H. T., Tang, Y., Lu, Q., Yuan, H. X., Wang, X., Liu, L. H., Zhu, D. X., & Wang, W. P. (2024). Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy.. Clin Hemorheol Microcirc, 86(3), 339-356. https://doi.org/10.3233/CH-231963

01/01/2024 Lire →